ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Projects Only 25% Of R01s Will Be Funded In FY89

November 25, 1988

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

March 16, 1984

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005